Overview | Q3 net profit of $0.97 billion, sales of major diet pills fell short of expectations, and full-year revenue guidance was lowered
Currency:USDOct 30, 2024
Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
Revenue | 12.12B | 11.44B | -679.50M |
Miss Est. | +27.58% | +20.43% | -5.61% |
EPS | 1.54 | 1.07 | -0.47 |
Miss Est. | +2677.80% | +1883.33% | -30.70% |
Dec 20, 2024
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Unlock Free Earnings Estimates
Read more
No Data